-
EP2853545
European procedure
Extract from the Register of European Patents
EP About this file: EP2853545
| EP2853545 - Antibody specific for IgE [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 31.03.2017 Database last updated on 01.04.2026 | Most recent event Tooltip | 03.03.2023 | Correction of patent specification | published on 05.04.2023 [2023/14] | Applicant(s) | For all designated states Xencor, Inc. 111 W. Lemon Avenue Monrovia, CA 91016 / US | [2023/13] |
| Former [2015/14] | For all designated states Xencor Inc. 111 W. Lemon Avenue Monrovia, CA 91016 / US | Inventor(s) | 01 /
Desjarlais, John R. 1030 North Michigan Avenue Pasadena, CA 91104 / US | 02 /
Chu, Seung Y. 4613 Larwin Ave Cypress, CA 90630 / US | 03 /
Horton, Holly M. 46 Parker Street Acton Massachusetts 01720 / US | [2015/14] | Representative(s) | HGF HGF Limited Mill House North Street York YO1 6JD / GB | [N/P] |
| Former [2015/14] | Taylor, Kate Laura HGF Limited Saviour House 9 St Saviourgate York YO1 8NQ / GB | Application number, filing date | 14188102.9 | 17.09.2009 | [2015/14] | Priority number, date | US20080097819P | 17.09.2008 Original published format: US 97819 P | [2015/14] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2853545 | Date: | 01.04.2015 | Language: | EN | [2015/14] | Type: | B1 Patent specification | No.: | EP2853545 | Date: | 25.05.2016 | Language: | EN | [2016/21] | Type: | B8 Corrected title page of specification | No.: | EP2853545 | Date: | 05.04.2023 | [2023/14] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 27.02.2015 | Classification | IPC: | C07K16/42, A61K39/395, A61P37/08 | [2015/14] | CPC: |
C07K16/4291 (EP,US);
A61K39/395 (KR);
A61P37/08 (EP,US);
C07K16/42 (KR);
C07K16/464 (US);
A61K2039/505 (EP,US);
C07K2317/24 (EP,US);
C07K2317/52 (EP,US);
C07K2317/732 (EP,US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2015/14] | Title | German: | Antikörper gegen IgE | [2015/14] | English: | Antibody specific for IgE | [2015/14] | French: | Anticorps spécifique pour IgE | [2015/14] | Examination procedure | 08.10.2014 | Examination requested [2015/14] | 01.10.2015 | Amendment by applicant (claims and/or description) | 26.11.2015 | Communication of intention to grant the patent | 05.04.2016 | Fee for grant paid | 05.04.2016 | Fee for publishing/printing paid | 05.04.2016 | Receipt of the translation of the claim(s) | 17.02.2023 | Request for correction of the decision to grant filed | Parent application(s) Tooltip | EP09792678.6 / EP2331578 | EP13185738.5 / EP2703415 | Divisional application(s) | EP16170993.6 / EP3190128 | Opposition(s) | 28.02.2017 | No opposition filed within time limit [2017/18] | 28.02.2017 | No opposition filed within time limit [2023/13] | Fees paid | Renewal fee | 08.10.2014 | Renewal fee patent year 03 | 08.10.2014 | Renewal fee patent year 04 | 08.10.2014 | Renewal fee patent year 05 | 08.10.2014 | Renewal fee patent year 06 | 28.09.2015 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HR | 25.05.2016 | [2016/51] | Documents cited: | Search | [A] US6037453 (JARDIEU PAULA M et al.) | [A] S. CHU ET AL.: "Inhibition of B cell receptor-mediated activation of primary human B cells by coengagement of CD19 and FcgammaRIIb with Fc-engineered antibodies.", MOLECULAR IMMUNOLOGY, vol. 45, no. 15, 8 August 2008 (2008-08-08), England, pages 3926 - 3933, XP002498116 DOI: http://dx.doi.org/10.1016/j.molimm.2008.06.027 | [A] S. WIGGINGTON ET AL.: "An immunoglobulin E-reactive chimeric human immunoglobulin G1 anti-idiotype inhibits basophil degranulation through cross-linking of FcepsilonRI with FcgammaRIIb.", CLINICAL AND EXPERIMENTAL ALLERGY, vol. 38, no. 2, 7 December 2007 (2007-12-07), England, pages 313 - 319, XP002555134 | by applicant | US2228904 | WO9211018 | US5693762 | US81050201 | US15315902 | US45900409 | US2009041144 | US6761889 | US6329509 | US2008003218 | US6066718 | US6072035 | US2004002894 | US5342924 | US5091313 | US5449760 | US5543144 | US5614611 | US12462005 | US15618308 | US6602684 | US27737002 | US11392902 | WO0061739 | WO0129246 | WO0231140 | WO0230954 | US90337801 | US75429604 | US24969205 | US2008088053 | WO2004004798 | WO2010033736 | LAZAR ET AL., MOL IMMUNOL, vol. 44, 2007, pages 1986 - 1998 | CHAMOW ET AL., TRENDS BIOTECHNOL, vol. 14, 1996, pages 52 - 60 | ASHKENAZI ET AL., CURR OPIN [MMUNOI, vol. 9, 1997, pages 195 - 200 | JEFFERIS ET AL., IMMUNOL LETT, vol. 82, 2002, pages 57 - 65 | DAVIS ET AL., IMMUNOLOGICAL REVIEWS, vol. 190, 2002, pages 123 - 136 | MOREA ET AL., BIOPHYS CHEM, vol. 68, 1997, pages 9 - 16 | MOREA ET AL., METHODS, vol. 20, 2000, pages 267 - 279 | MAYNARD ET AL., ANNU REV BIOMED ENG, vol. 2, 2000, pages 339 - 376 | RAGHAVAN ET AL., ANNU REV CELL DEV BIOL, vol. 12, 1996, pages 181 - 220 | RAVETCH ET AL., ANNU REV IMMUNOL, vol. 19, 2001, pages 275 - 290 | GHETIE ET AL., ANNU REV IMMUNOL, vol. 18, 2000, pages 739 - 766 | RAVETCH ET AL., ANNU REV LMMUNOL, vol. 19, 2001, pages 275 - 290 | SONDERMANN ET AL., J MOL BIOL, vol. 309, 2001, pages 737 - 749 | SONDERMANN ET AL., NATURE, vol. 406, 2000, pages 267 - 273 | RADAEV ET AL., J BIOL CHEM, vol. 276, 2001, pages 16469 - 16477 | GHETIE ET AL., ANNU REV IMMUNOL, vol. 18, 2000, pages 739 - 766 | UMANA ET AL., NAT BIOTECHNOL, vol. 17, 1999, pages 176 - 180 | DAVIES ET AL., BIOTECHNOL BIOENG, vol. 74, 2001, pages 288 - 294 | MIMURA ET AL., J BIOL CHEM, vol. 276, 2001, pages 45539 - 45547 | RADAEV ET AL., J BIOL CHEM, vol. 276, 2001, pages 16478 - 16483 | SHIELDS ET AL., J BIOL CHEM, vol. 276, 2001, pages 6591 - 6604 | SHIELDS ET AL., J BIOL CHEM, vol. 277, 2002, pages 26733 - 26740 | SIMMONS ET AL., J LMMUNOL METHODS, vol. 263, 2002, pages 133 - 147 | CHAMOW ET AL., TRENDS SIOTECHNOT, vol. 14, 1996, pages 52 - 60 | ASHKENAZI, CURR OPIN IMMUNOL, vol. 9, 1997, pages 195 - 200 | CHAMOW ET AL., TRENDS BIOTECHNO, vol. 14, 1996, pages 52 - 60 | ASHKENAZI ET AL., CURR OPIN IMMUNOL, vol. 9, 1997, pages 195 - 200 | "Pierce Chemical Company catalog", 1994, pages: 155 - 200 | CLARK, 1GG EFFECTOR MECHANISMS, CHEM IMMUNOL., vol. 65, 1997, pages 88 - 110 | GORMAN; CLARK, SEMIN LMMUNOL, vol. 2, no. 6, 1990, pages 457 - 66 | J IMMUNOGEN, vol. 3, 1976, pages 357 - 362 | EUR. J. IMMUNOL., vol. 6, 1976, pages 599 - 601 | LOGHEM E VAN, ALLOTYPIC MARKERS, MONOGR ALLERGY, vol. 19, 1986, pages 40 - 51 | KIM ET AL., J. MOL. EVOL., vol. 54, 2001, pages 1 - 9 | LEFRANC ET AL.: "The human IgG subclasses: molecular analysis of structure, function and regulation", 1990, PERGAMON, pages: 43 - 78 | LEFRANC, G. ET AL., HUM. GENET., vol. 50, 1979, pages 199 - 211 | HOLLIGER; HUDSON, NATURE BIOTECHNOLOGY, vol. 23, no. 9, 2006, pages 1126 - 1136 | CARTER, NATURE REVIEWS IMMUNOLOGY, vol. 6, 2006, pages 343 - 357 | JONES, NATURE, vol. 321, 1986, pages 522 - 525 | VERHOEYEN ET AL., SCIENCE, vol. 239, 1988, pages 1534 - 1536 | ROQUE ET AL., BIOTECHNOL. PROG., vol. 20, 2004, pages 639 - 654 | TSURUSHITA; VASQUEZ: "Humanization of Monoclonal Antibodies, Molecular Biology of B Cells", 2004, ELSEVIER SCIENCE, pages: 533 - 545 | ROGUSKA ET AL., PROC. NATL. ACAD. SCI. USA, vol. 91, 1994, pages 969 - 973 | TAN ET AL., J. IMMUNAL., vol. 169, 2002, pages 1119 - 1125 | DE PASCALIS ET AL., J. IMMUNOL., vol. 169, 2002, pages 3076 - 3084 | LAZAR ET AL., MOLLMMUNOL, vol. 44, 2007, pages 1986 - 1998 | BRUGGEMANN ET AL., CURR OPIN BIOTECHNOL, vol. 8, 1997, pages 455 - 458 | GRIFFITHS ET AL., CURR OPIN BIOTECHNOL, vol. 9, 1998, pages 102 - 108 | PRESTA, LG ET AL., J IMMUNOL, vol. 151, 1993, pages 2623 - 2632 | CORNE, J ET AL., J CLIN INVEST, vol. 99, 1997, pages 879 - 887 | RACINE-POON, A ET AL., CLIN PHARMCOL THER, vol. 62, 1997, pages 675 - 690 | KOLBINGER, F ET AL., PROTEIN ENG, vol. 6, 1993, pages 971 - 980 | KABAT ET AL.: "Sequences of Proteins of Immunological Interest, 5th Ed.,", 1991, NATIONAL INSTITUTES OF HEALTH | EDELMAN ET AL., PROC NATL ACAD SCI USA, vol. 63, 1969, pages 78 - 85 | DAVIS ET AL., LMMUNOL. REVIEWS, vol. 190, 2002, pages 123 - 136 | LIFELY ET AL., GLYCOBIOLOGY, vol. 5, no. 8, 1995, pages 813 - 822 | JEFFERIS ET AL., LMMUNOL. REV., vol. 163, 1998, pages 59 - 76 | WRIGHT ET AL., TRENDS BIOTECH, vol. 15, 1997, pages 26 - 32 | HUBBARD ET AL., ANN. REV. BIOCHEM., vol. 50, 1981, pages 555 - 583 | KABAT ET AL., SEQUENCES OF PROTEINS OF IMMUNOLOGICAL INTEREST, 1991 | STANLEY, J. BIOL. CHEM., vol. 261, 1984, pages 13370 - 13378 | UMANA ET AL., NATURE BIOTECH., vol. 17, 1999, pages 176 - 180 | SHINKAWA ET AL., J BIOL CHEM, vol. 278, 2003, pages 3466 - 3473 | LI ET AL., NATURE BIOTECHNOLOGY, vol. 24, no. 2, 2006, pages 210 - 215 | NECHANSKY ET AL., MOL LMMUNJOL, vol. 44, no. 7, 2007, pages 1826 - 8 | COX ET AL., NAT BIOTECHNOL, vol. 24, no. 12, 2006, pages 1591 - 7 | SCALLON ET AL., MOL IMMUNOL, vol. 44, no. 7, 2007, pages 1524 - 34 | KANEKO ET AL., SCIENCE, vol. 313, 2006, pages 670 - 673 | T.E. CREIGHTON: "Proteins: Structure and Molecular Properties", 1983, W.H. FREEMAN & CO., pages: 79 - 86 | CROPP; SHULTZ, TRENDS GENET., vol. 20, no. 12, 2004, pages 625 - 30 | ANDERSON ET AL., PROC. NATL. ACAD. SCI. U.S.A., vol. 101, no. 2, 2004, pages 7566 - 71 | CHIN ET AL., SCIENCE, vol. 301, no. 5635, 2003, pages 964 - 7 | HINTON ET AL., J. BIOL. CHEM., vol. 279, no. 8, 2004, pages 6213 - 6216 | HINTON ET AL., JOURNAL OF IMMUNOLOGY, vol. 176, 2006, pages 346 - 356 | SHIELDS ET AL., JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 276, no. 9, 2001, pages 6591 - 6604 | DALL ACQUA ET AL., JOURNAL OF IMMUNOLOGY, vol. 169, 2002, pages 5171 - 5180 | DALL'ACQUA ET AL., THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 281, 2006, pages 23514 - 23524 | TRAIL ET AL., CURR. OPIN. LMMUNOL., vol. 11, 1999, pages 584 - 588 | PENICHET ET AL., J. IMMUNE!. METHODS, vol. 248, 2001, pages 91 - 101 | DUEBEL & KONTERMANN,: "Antibody Engineering", 2001, SPRINGER-VERLAG | HAYHURST; GEORGIOU, CURR OPIN CHEM BIOL, vol. 5, 2001, pages 683 - 689 | MAYNARD; GEORGIOU, ANNU REV BIOMED ENG, vol. 2, 2000, pages 339 - 76 | HARLOW; LANE: "Antibodies: A Laboratory Manual", 1988, COLD SPRING HARBOR LABORATORY PRESS | MANIATIS: "Molecular Cloning - A Laboratory Manual, 3d Ed.", 2001, COLD SPRING HARBOR LABORATORY PRESS | KAY ET AL.: "Phage display of peptides and proteins: a laboratory manual", 1996, ACADEMIC PRESS | LOWMAN ET AL., BIOCHEMISTRY, vol. 30, 1991, pages 10832 - 10838 | SMITH, SCIENCE, vol. 228, 1985, pages 1315 - 1317 | SCOPES: "Protein Purification: Principles and Practice, 3rd Ed.,", 1994, SPRINGER-VERLAG | MECHETINA ET AL., IMMUNOGENETICS, vol. 54, 2002, pages 463 - 468 | ARBES ET AL.: "Prevalences of positive skin test responses to 10 common allergens in the US population: Results from the Third National Health and Nutrition Examination Survey", CLINICAL GASTROENTEROLOGY, vol. 116, no. 2, 2005, pages 377 - 383, XP005002826, DOI: doi:10.1016/j.jaci.2005.05.017 DOI: http://dx.doi.org/10.1016/j.jaci.2005.05.017 | OSOL, A.: "Remington's Pharmaceutical Sciences 16th edition,", 1980 | BITONTI, PROC. NAT. ACAD. SCI., vol. 101, 2004, pages 9763 - 8 | CARAMORI ET AL., JOURNAL OF OCCUPATIONAL MEDICINE AND TOXICOLOGY, vol. 3, 2008, pages 81 - 86 |